VariablePróximamente
NovexisCJC-1295
THB 0
Seleccionar opción
—
OVERVIEW
CJC-1295 without DAC 5mg + IPA 5mg
This peptide combination features CJC-1295 without DAC paired with Ipamorelin to study synergistic growth hormone release pathways and recovery signaling.
Envío gratis
Pedidos desde ฿500
Devolución gratis
En 30 días
Garantía
100% original
Entrega cuidadosa
Embalaje seguro
OVERVIEW
This peptide combination features CJC-1295 without DAC paired with Ipamorelin to study synergistic growth hormone release pathways and recovery signaling.
TYPICAL RESEARCH DOSING
Typical research use ranges from 100–300mcg per peptide, administered 1–3 times daily.
PRIMARY RESEARCH APPLICATION
- Growth hormone secretion studies
- Recovery and performance pathway research
- Sleep and recovery investigations
- IGF-1 modulation studies
KEY RESEARCH BENEFITS
- Synergistic stimulation of GH pathways
- Investigated for pulsatile GH release patterns
- Supports recovery and tissue repair research
- Frequently utilized in metabolic and endocrine models